Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions

By Egeler R.M.   Favara B.E.   Laman J.D.   Claassen E.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2105-2110

Elsevier

Access to resources Recommend Favorite

Method for the validation of immunohistochemical staining using SCID mouse xenografts: Expression of CD40 and CD154 in human non-small cell lung cancer

By                                    

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1315-1321

Spandidos Publications

Access to resources Recommend Favorite

The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer

By Zhang Zhen   Xu Xiaoling   Zhang Xiaoren   Chen Xiqian   Chen Qingge   Dong Lina   Hu Zhiming   Li Jinlong   Gao Jimin  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1111-1118

Informa Healthcare

Access to resources Recommend Favorite

Ongoing Studies with GM.CD40L Bystander-Based Vaccines

By Dessureault Sophie  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1255-1255

Springer Publishing Company

Access to resources Recommend Favorite

A phase-I Trial Using a Universal GM-CSF-producing and CD40L-expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-based Vaccines for Cancer Patients with Stage IV disease

By Dessureault Sophie   Noyes David   Lee David   Dunn Mary   Janssen William   Cantor Alan   Sotomayor Eduardo   Messina Jane   Antonia Scott  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 869-884

Springer Publishing Company

Access to resources Recommend Favorite